IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Flagship Pioneering, LLC

Q4 2023 Holdings

Filed 2024-02-14 | 13 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Moderna Inc(MRNA)COM60770K107$961.3M9,666,03872.5%
Sana Biotechnology Inc(SANA)COM799566104$102.0M25,001,8567.7%
Omega Therapeutics IncCOM68217N105$88.0M29,225,5796.6%
Foghorn Therapeutics Inc(FHTX)COM344174107$81.7M12,674,1206.2%
Denali Therapeutics Inc(DNLI)COM24823R105$49.8M2,319,9683.8%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$32.4M23,117,0452.4%
Syros Pharmaceuticals Inc(SYRS)COM87184Q206$10.1M1,293,8480.8%